Newsfeeds - Spark Newswire

1 minute read

Inflation, Pressure on Consumers’ Discretionary Spending Bite Into Signet Jewelers’ Future Outlook

Today, 4:02 AM

Diamond jewelry retailer Signet Jewelers Ltd (NYSE:SIG) reported a second-quarter FY23 sales decline of 1.9% year-on-year to $1.755 billion, marginally beating the…

SIG

1 minute read

Earnings

Recap: Signet Jewelers Q2 Earnings

By Benzinga Insights

Today, 4:02 AM

Signet Jewelers (NYSE:SIG) reported its Q2 earnings results on Thursday, September 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

SIG

3 minute read

Earnings

Earnings Scheduled For September 1, 2022

By Benzinga Insights

Today, 4:02 AM

Companies Reporting Before The Bell • Hello Gr (NASDAQ:MOMO) is projected to report quarterly earnings at $0.25 per share on revenue of $445.33 million.

AVGO

2 minute read

Looking Into Signet Jewelers Recent Short Interest

By Benzinga Insights

Today, 4:02 AM

SIG

1 minute read

Here’s How Much $100 Invested In Signet Jewelers 15 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 4:02 AM

Signet Jewelers (NYSE:SIG) has outperformed the market over the past 15 years by 1.35% on an annualized basis producing an average annual return of 8.75%. Currently, Signet Jewelers has a market capitalization of $3.24 billion.

SIG

3 minute read

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday

By Lisa Levin

Today, 4:02 AM

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.

AEO

9 minute read

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

By Lisa Levin

Today, 4:02 AM

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

AEL

6 minute read

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 4:02 AM

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

AEL